Therefore, the pathogenesis of COVID-19 and RA is similar in that the inflammatory state in the pathogenesis of both diseases activates the JAK-STAT and NF-κB signaling pathways (Fig. 2), which offers possibilities for the therapy of RA patients infected by SARS-CoV-2. This evidence concerns the gene NFKB1 and COVID-19.